Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Lefkowitz | M | 68 | 13 years | |
Michael Handley | M | 52 | 3 years | |
Myron Kaplan | M | 79 | 8 years | |
Paul Hastings | M | 64 | 13 years | |
Kristen Williams | F | 50 | 13 years | |
Gary Pace | M | 76 | 16 years | |
Robert Stein | M | 73 | 4 years | |
Laura Brege | F | 66 | 13 years | |
Mark Kronenfeld | M | 69 | 11 years | |
Janet Dillione | F | 65 | 9 years | |
C. Satish Chandran | M | 68 | 2 years | |
Lauren Riker | F | 45 | 12 years | |
Nir Dror | M | 47 | 4 years | |
Charles Reinhart | M | 63 | 13 years | |
Robert W. Buckheit | M | 63 | 3 years | |
Susan Mesco | F | - | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mohammed Khoso Baluch | M | 66 | 5 years | |
Randy Milby | M | 70 | 4 years | |
Gary A. Gelbfish | M | 65 | 5 years | |
Scott Braunstein | M | 60 | 3 years | |
Steve Barbarick | M | 56 | 1 years | |
Lea Verny | F | 59 | 1 years | |
Yvonne Greenstreet | M | 61 | 9 years | |
Luke Evnin | M | 60 | 7 years | |
Mehmood Khan | M | 66 | 3 years | |
Richard Scranton | M | 57 | 9 years | |
Joseph Amprey | M | - |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | 6 years |
Randy Steven Saluck | M | 59 | 1 years | |
Mark Walters | M | 69 | 5 years | |
James Scibetta | M | 59 | 9 years | |
George Michael | M | 75 | 3 years | |
John L. Armstrong | M | 80 | 7 years | |
Harry O'Grady | M | 62 | 1 years | |
Cora M. Tellez | F | 74 | 3 years | |
Dennis L. Winger | M | 77 | 5 years | |
Bob Cook | M | 68 | 3 years | |
Carl Gordon | M | 59 | 5 years | |
Judith Abrams | M | 64 | - | |
Cozette M. McAvoy | F | 45 | 1 years | |
Sergio Alegre | M | - | 4 years | |
Dennis Mcloughlin | M | 58 | - | |
John Ortiz | M | - | - | |
Richard Kahr | M | - | 8 years | |
Clifford A. Selsky | M | 76 | 1 years | |
Nikki Adetoro | F | - |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | - |
Vinay Shah | M | 62 | 8 years | |
Harry Kovelman | M | 65 | 3 years | |
Stanley Stern | M | 67 | 1 years | |
Stephen Haworth | M | - | 1 years | |
Paul R. Ellwood | M | - | - | |
David St. Peter | M | - | 1 years | |
James B. Jones | M | 59 | - | |
William J. Lambert | M | 65 | 4 years | |
James R. Altland | M | 75 | 2 years | |
Tim M. Ciaccio | M | - | - | |
Fred M. Ryan | M | 72 | - | |
Gary Patou | M | 65 | 6 years | |
Peter J. Aronstam | M | 72 | 1 years | |
Fred Middleton | M | 74 | 7 years | |
Cynthia Douglas | F | 51 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 57 | 95.00% |
Israel | 3 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Taunia S. Markvicka
- Personal Network